ライフサイエンスコーパス: Gram

1 Gram-negative bacteremia is a common infection that resu

2 Gram-negative bacteria and their complex cell envelope,

3 Gram-negative bacteria are surrounded by an outer membra

4 Gram-negative bacteria have a cell envelope that compris

5 Gram-negative bacteria have evolved numerous pathways to

6 Gram-negative bacteria release outer membrane vesicles i

7 Gram-negative bacteria repopulated in the smokers faster

8 Gram-negative bacteria, mitochondria, and chloroplasts a

9 Gram-negative bacterial infections are a significant pub

10 Gram-negative bacterial lipoproteins are triacylated wit

11 Gram-negative bloodstream infections represent a signifi

12 Gram-negative intestinal domination was associated with

13 Gram-negative pathogens are enveloped by an outer membra

14 Gram-positive bacteria have developed secretion systems

15 Gram-scale production has been realized, paving the way

16 Gram-scale synthesis provided an acrylamide analogue, wh

17 nel to other methods of identification of 20 Gram-positive bacteria, four antimicrobial resistance ge

18 lecular methods for the identification of 20 Gram-positive pathogens and four antimicrobial resistanc

19 eptibility testing using a collection of 297 Gram-negative bacilli, including members of the order En

20 of available genome sequences of over 1,300 Gram-negative strains.

21 not included): Gram-positive bacteria, 58%; Gram-negative bacteria, 78%; and Candida species, 83%.

22 The MICs of CFDC were determined for 610 Gram-negative bacilli, including 302 multinational Enter

23 Pseudomonas aeruginosa, a Gram-negative bacterium that commonly colonizes the airw

24 Filifactor alocis, a Gram-positive anaerobic bacterium, is now a proposed dia

25 y known requirements for PIC targeting are a Gram-negative cell envelope and a unique cell surface an

26 Klebsiella pneumoniae is a Gram-negative bacterial pathogen that causes a range of

27 Stenotrophomonas maltophilia is a Gram-negative bacterium found ubiquitously in the enviro

28 inosa IMPORTANCE Pseudomonas aeruginosa is a Gram-negative bacterium frequently isolated from infecte

29 ica serovar Typhimurium (S Typhimurium) is a Gram-negative bacterium that induces cell death of macro

30 Vibrio cholerae is a Gram-negative human pathogen and the causative agent of

31 C. burnetii is a Gram-negative intracellular bacterium that replicates wi

32 Proteus mirabilis is a Gram-negative uropathogen and frequent cause of catheter

33 Clostridium difficile is a Gram-positive bacterium with an S-layer covering its pep

34 Abiotrophia defectiva is a Gram-positive pleomorphic bacterium, commonly found in t

35 Listeria monocytogenes is a Gram-positive, intracellular pathogen harboring the surf

36 Clostridioides difficile is a Gram-positive, spore-forming, anaerobic bacterium that i

37 o damage caused by Listeria monocytogenes, a Gram-positive bacterium, BCV rupture by Gram-negative pa

38 K), which is the first characterization of a Gram-positive NanK.

39 Klebsiella pneumoniae, a Gram-negative bacterium, is notorious for causing HAI, w

40 ed the presence of RgNanOx homologues across Gram-negative and Gram-positive bacterial species and co

41 array of multidrug-resistant (MDR), aerobic Gram-negative bacilli.

42 stigation of novel substances active against Gram-negative bacteria.

43 erophore cephalosporin with activity against Gram-negative bacterial species that are resistant to ca

44 ot have clinically relevant activity against Gram-positive or anaerobic organisms.

45 treptogramins(2), potent antibiotics against Gram-positive bacteria that inhibit the bacterial riboso

46 -deoxyglucosone (3-DG) were assessed against Gram-positive and Gram-negative pathogenic and food spoi

47 high level in E. coli, is effective against Gram-negative clinical isolates, and has efficacy in mou

48 oglycoside antibiotics are effective against Gram-negative infections, these drugs often cause irreve

49 obial activity, with higher efficacy against Gram-positive strains than Gram-negative ones.

50 We test the system against Gram-positive (Bacillus subtilis) and Gram-negative (Esc

51 hibitory concentration (MIC) values] against Gram-positive bacteria.

52 OMP folding is an essential process in all Gram-negative bacteria, and considering the looming cris

53 hylenediaminetetraacetic acid) inhibited all Gram-negative and Gram-positive bacteria tested.

54 Among Gram-negative bacteria, Escherichia coli were predominan

55 Given that ompA is highly conserved among Gram-negative pathogens, these studies not only provide

56 us (43%), followed by streptococci (26%) and Gram negative rods (18%).

57 am stain-negative Pseudomonas aeruginosa and Gram stain-positive Staphylococcus aureus bacteria, indu

58 ed Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial pathogens as

59 Mitochondria, chloroplasts and Gram-negative bacteria are encased in a double layer of

60 Gram-negative Escherichia coli (E. coli) and Gram-positive Enterococcus durans (E. durans) and Staphy

61 acetic acid) inhibited all Gram-negative and Gram-positive bacteria tested.

62 ghput scRNA-seq method for Gram-negative and Gram-positive bacteria that can resolve heterogeneous tr

63 gle-cell transcriptomes of Gram-negative and Gram-positive bacteria with high purity and low bias, wi

64 cultures in patients with Gram-negative and Gram-positive bacteria, including 8/60 (13.3%) patients

65 RgNanOx homologues across Gram-negative and Gram-positive bacterial species and co-occurrence with s

66 -free readout on unlabeled Gram-negative and Gram-positive species.

67 vity extends to a range of Gram-negative and Gram-positive wound pathogens in planktonic culture and,

68 zed filters quickly killed Gram-positive and Gram-negative bacteria aerosols in vitro, with CFU reduc

69 that neutrophils recognize Gram-positive and Gram-negative bacteria by means of multiple phagosomal T

70 The proportion of Gram-positive and Gram-negative bacteria were 135(68.2%) and 63(31.8%) res

71 ctivity against the tested Gram-positive and Gram-negative bacteria, with a large zone of inhibition

72 occus aureus, representing Gram-positive and Gram-negative bacteria.

73 ell wall component of both Gram-positive and Gram-negative bacteria.

74 ion and penetration of the Gram-positive and Gram-negative bacterial cell envelope, but do not ruptur

75 is of intact proteins from Gram-positive and Gram-negative bacterial colonies sampled directly on sol

76 -DG) were assessed against Gram-positive and Gram-negative pathogenic and food spoilage bacteria, bot

77 lied for Gram-positive Bacillus subtilis and Gram-negative Escherichia coli as model organisms to mon

78 gainst Gram-positive (Bacillus subtilis) and Gram-negative (Escherichia coli) targets.

79 ed Gram-negative Escherichia coli Symbio and Gram-positive Enterococcus faecalis Symbio or placebo fr

80 athogens and mixed infections with yeast and Gram-negative organisms from the same positive blood cul

81 tions in this study were caused by bacteria; Gram-positive bacteria were responsible for most cases.

82 Horizontal gene transfer between Gram-positive bacteria leads to a rapid spread of virule

83 with yeast cells and various strains of both Gram-positive and -negative bacteria revealed distinct b

84 lycan (PGN) is a cell wall component of both Gram-positive and Gram-negative bacteria.

85 degree of bactericidal activity toward both Gram stain-negative Pseudomonas aeruginosa and Gram stai

86 kines were quantified in keratitis caused by Gram-negative bacteria.

87 As 80% of prostatitis cases are caused by Gram-negative uropathogenic Escherichia coli (UPEC) or G

88 hronic inflammatory disease characterized by Gram-negative bacteria responsible for the degradation o

89 IEps by Gram-negative bacteria (n = 210) outnumbered those by Gr

90 Outer membrane vesicles (OMVs) produced by Gram-negative bacteria have roles in cell-to-cell signal

91 an early predictive marker of BCV rupture by Gram-negative bacteria.

92 s, a Gram-positive bacterium, BCV rupture by Gram-negative pathogens such as Shigella flexneri or Sal

93 tive bacteria (n = 210) outnumbered those by Gram-positive bacteria (n = 142).

94 Here we highlight defenses utilized by Gram-negative cells against type VI secretion system (T6

95 fiderocol susceptibility results for certain Gram-negative bacilli.

96 ted using a cohort of contemporary, clinical Gram-negative bacillus isolates from 3 U.S. academic med

97 Here, we show that the cytosolic Gram-negative bacterium Shigella flexneri stalls apoptos

98 Ellisiiamide A demonstrated Gram-negative activity against Escherichia coli BW25113,

99 cell wall is widely conserved across diverse Gram-negative bacteria.

100 S in vitro and inhibit the growth of diverse Gram-negative bacteria, including polymyxin-resistant st

101 eonatal mice to more severe infection during Gram-negative sepsis.

102 antimicrobial resistance phenotypes, during Gram-negative bacterial infection and will advance our u

103 his breaks the dogma that beta-lactams enter Gram-negative bacteria only by passive diffusion through

104 el area for antimicrobial discovery to fight Gram-positive and S. aureus infections.

105 For Gram-negative cultures, the Verigene result correlated w

106 to unnecessary escalation of antibiotics for Gram-negative BSIs.

107 he proposed EAST is successfully applied for Gram-positive Bacillus subtilis and Gram-negative Escher

108 tomography-guided fine-needle aspiration for Gram stain and cultures is unnecessary in the majority o

109 (P < 0.0001)-with pronounced differences for Gram-negative bacteria and Candida species.

110 ay of isoprenoid synthesis, is essential for Gram-negative bacteria, mycobacteria and apicomplexans(2

111 he third ring was particularly important for Gram-negative activity.

112 ics), a high-throughput scRNA-seq method for Gram-negative and Gram-positive bacteria that can resolv

113 RDT facilitated antibiotic optimization for Gram-positive BSIs but led to unnecessary escalation of

114 ificities, moderately high sensitivities for Gram-negative bacteria and Candida species, and elevated

115 ST (median, 23 vs 7.4 hours, P < .001), from Gram stain to optimal therapy (median, 11 vs 7 hours, P

116 Lipopolysaccharide derived from Gram-negative bacteria is a potent activator of circulat

117 on the biogenesis and functions of EVs from Gram-positive bacteria and identify key areas for future

118 lied to the analysis of intact proteins from Gram-positive and Gram-negative bacterial colonies sampl

119 use of ADX significantly decreased time from Gram stain to ID (median, 23 vs 2.2 hours, P < .001) and

120 y; however, there is little knowledge on how Gram-negative bacteria release their OMs into their envi

121 enMark Dx ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel is a multiplex nucleic aci

122 he virulence of numerous medically important Gram-positive bacteria.

123 ts on a benzisoxazole scaffold with improved Gram-positive antibacterial activity relative to previou

124 In Gram-negative bacteria, PG is assembled in the cytoplasm

125 In Gram-negative bacteria, the folding and insertion of bet

126 e pathway that produces phosphatidic acid in Gram-positive bacteria.

127 t only in Gram-positive bacteria but also in Gram-negative C. jejuni, advancing our knowledge of the

128 ntimicrobial susceptibility testing (AST) in Gram-negative rod (GNR) bacteremia is compelling; howeve

129 the beta-barrel assembly machinery (BAM) in Gram-negative bacteria, and by the sorting and assembly

130 s toward understanding betaOMP biogenesis in Gram-negative bacteria and in mitochondria.

131 Cell-surface signaling (CSS) in Gram-negative bacteria involves highly conserved regulat

132 re key antibiotic resistance determinants in Gram-negative bacteria.

133 nhances combinatorial antigenic diversity in Gram-negative bacteria, while reducing associated fitnes

134 eptation is critical to faithful division in Gram-negative bacteria and vital to the barrier function

135 o differences in cell wall structure, EVs in Gram-positive bacteria have been disregarded for decades

136 igenetic regulation of cellular functions in Gram-positive bacteria.

137 fied antimicrobial resistance (AMR) genes in Gram-negative bacteria.

138 mids carrying antibiotic resistance genes in Gram-positive bacteria.

139 A major resistance mechanism in Gram-negative bacteria is the production of beta-lactama

140 nally, we discover aminoacyl-PGs not only in Gram-positive bacteria but also in Gram-negative C. jeju

141 gulates the biosynthesis of phospholipids in Gram-positive bacteria.

142 Carbapenem resistance in Gram-negative bacteria is a public health concern.

143 prevalent cause of antibiotic resistance in Gram-negative bacteria, i.e., the deactivation of the mo

144 d enzymes that confer colistin resistance in Gram-negative bacteria.

145 uring LPS transfection; however, its role in Gram-negative bacteria-mediated NLRP3 inflammasome activ

146 catechol species are important Fe sources in Gram-positive human pathogens, since PiuA functions in t

147 ars ago and have been extensively studied in Gram-negative bacteria.

148 is an uncharacterized protein ubiquitous in Gram-negative bacteria whose gene frequently occurs in c

149 division (RND) superfamily are ubiquitous in Gram-negative bacteria.

150 CTX-M beta-lactamases are widespread in Gram-negative bacterial pathogens and provide resistance

151 vitro infection model with heat-inactivated Gram-positive (Staphylococcus aureus) and Gram-negative

152 icrobiota assessments at all visits included Gram stain Nugent scoring and 16S rRNA gene qPCR and HiS

153 gulase-negative staphylococci not included): Gram-positive bacteria, 58%; Gram-negative bacteria, 78%

154 ority pathogens listed by the WHO, including Gram-negative bacteria in the critical priority category

155 lity of most drug leads to accumulate inside Gram-negative bacteria(1-7).

156 a bacterial lysate consisting of heat-killed Gram-negative Escherichia coli Symbio and Gram-positive

157 e salt-functionalized filters quickly killed Gram-positive and Gram-negative bacteria aerosols in vit

158 Many Gram-negative bacterial pathogens antagonize anti-bacter

159 Many Gram-negative bacterial pathogens interact with mammalia

160 Many Gram-negative pathogens use a type III secretion system

161 Many Gram-positive Firmicutes also have N-acylated lipoprotei

162 S) are essential envelope components in many Gram-negative bacteria and provide intrinsic resistance

163 ng virulence and conjugation operons in many Gram-negative bacterial pathogens.

164 n resistance methyltransferase found in many Gram-positive pathogens, whereas ErmE is found in the so

165 SS) is a pivotal virulence mechanism of many Gram-negative bacteria.

166 m-resistant and/or multidrug-resistant (MDR) Gram-negative bacteria in clinical settings.

167 h activity against multidrug-resistant (MDR) Gram-negative pathogens as the pipeline of antibiotics i

168 e restricted the analysis to donors with MDR-Gram-negative (GN) organisms.

169 on between cell envelopes with one membrane (Gram-positive or monoderm) and those with two membranes

170 e or monoderm) and those with two membranes (Gram-negative or diderm) is a fundamental open question

171 ral Vibrio species and a set of monotrichous Gram-negative bacteria.

172 control of Pseudomonas aeruginosa, a motile Gram-negative, opportunistic bacterial pathogen which fr

173 d bloodstream infection due to nonfermenting Gram-negative bacilli (odds ratio, 6.33; 95% CI, 1.59-25

174 lar catheter infections due to nonfermenting Gram-negative bacilli was high for the femoral insertion

175 ized arterial catheters due to nonfermenting Gram-negative bacilli were more frequently observed at t

176 This modification occurs in numerous Gram-positive pathogens, including methicillin-resistant

177 (DD) to broth microdilution (BMD) for AST of Gram-negative bacilli (GNB).

178 nd a general blueprint for the conversion of Gram-positive-only compounds into broad-spectrum antibio

179 The cell envelope of Gram-negative bacteria is a multilayered structure essen

180 ltiprotein system present in the envelope of Gram-negative bacteria.

181 The cell envelope of Gram-positive bacteria generally comprises two types of

182 mes that are secreted by almost all forms of Gram-negative bacteria.

183 This study investigated the inactivation of Gram-negative Escherichia coli (E. coli) and Gram-positi

184 .3% specificity as a diagnostic indicator of Gram-ve infection.

185 has been widely used to treat infections of Gram-positive bacteria including Clostridium difficile a

186 eate antibody-mediated uptake and killing of Gram-positive pathogens remain extremely limited.

187 positive bacteria and lipopolysaccharides of Gram-negative bacteria.

188 The LPS of Gram-negative bacteria have been shown to activate a nov

189 The highly asymmetric outer membrane of Gram-negative bacteria functions in the defense against

190 The outer-membrane of Gram-negative bacteria is critical for surface adhesion,

191 aride (LPS) resides in the outer membrane of Gram-negative bacteria where it is responsible for barri

192 lethanolamine/phosphatidylglycerol mimics of Gram-negative cytoplasmic membranes.

193 We use our findings to propose a model of Gram-negative cell envelope stabilization that includes

194 Most of Gram-positive bacteria anchor surface proteins to the pe

195 re strongly associated with lower numbers of Gram-negative organisms at indoor sites (p < 0.0001).

196 rimeric porins in the outer membrane (OM) of Gram-negative bacteria are the conduits by which nutrien

197 The asymmetric outer membrane (OM) of Gram-negative bacteria functions as a selective permeabi

198 The outer membrane (OM) of Gram-negative bacteria is a selective permeability barri

199 The outer membrane (OM) of Gram-negative bacteria is an asymmetric lipid bilayer th

200 Recent recurrent outbreaks of Gram-negative bacteria show the critical need to target

201 s) play an important role in pathogenesis of Gram-negative infections.

202 lecular patterns including peptidoglycans of Gram-positive bacteria and lipopolysaccharides of Gram-n

203 d in 70% of patients, with a predominance of Gram-positive bacteria (93%).

204 diatric institution with a low prevalence of Gram-negative resistance, the VG RDT facilitated antibio

205 The proportion of Gram-positive and Gram-negative bacteria were 135(68.2%)

206 bactericidal activity extends to a range of Gram-negative and Gram-positive wound pathogens in plank

207 a potent antibiotic against a broad range of Gram-positive bacteria, but its medical applications hav

208 Pseudoalterin binds to the glycan strands of Gram positive bacterial PG and degrades the PG peptide c

209 g proteins (GBPs) assemble on the surface of Gram-negative bacteria into polyvalent signaling platfor

210 I-seq captures single-cell transcriptomes of Gram-negative and Gram-positive bacteria with high purit

211 vancomycin is a mainstay in the treatment of Gram-positive infection.

212 ommonly used clinically for the treatment of Gram-positive skin and skin structure infections (SSSI),

213 anscription of foreign genes in a variety of Gram-negative bacterial species.

214 On Gram-negative bacteria, S-layers are anchored to cells v

215 The focus is on Gram-negative pathogens, particularly bacteria on the WH

216 ase hepcidin in response to Gram-negative or Gram-positive infection.

217 ive uropathogenic Escherichia coli (UPEC) or Gram-positive Enterococcus faecalis, we used a mouse tra

218 Nonetheless, Listeria and other Gram-positive bacteria have evolved an impressively dive

219 used by staphylococci, enterococci and other Gram-positive bacteria.

220 l envelope stability(4); however, most other Gram-negative bacteria lack Lpp so it has been assumed t

221 sistance genes, and both Pan Candida and Pan Gram-Negative targets that are unique to the BCID-GP Pan

222 greement and NPA for the Pan Candida and Pan Gram-Negative targets were 92.4% and 95.7% for the forme

223 ects survival to infection by the pathogenic Gram-positive bacterium Micrococcus luteus.

224 resistant (XDR) and pan-drug-resistant (PDR) Gram-negative pathogens.

225 curvulamine, a dimeric member with promising Gram-positive and -negative antibiotic activity.

226 Cases were defined as 3GC-R-BSI or 3GC-R Gram-negative infection (3GC-R-GNI) (analysis 2), all ot

227 ly, our data show that neutrophils recognize Gram-positive and Gram-negative bacteria by means of mul

228 nosa and Staphylococcus aureus, representing Gram-positive and Gram-negative bacteria.

229 1500 ppm) as well as sensitive and resistant Gram negative (using 125 ppm) bacteria.

230 acterial assays with wild-type and resistant Gram negative bacteria carrying either single or multipl

231 ctivity against both sensitive and resistant Gram positive (using 1500 ppm) as well as sensitive and

232 Carbapenem-resistant Gram-negative bacteria (GNB) are heading the list of pat

233 with infections due to carbapenem-resistant Gram-negative organisms.

234 ent activity against ciprofloxacin-resistant Gram-negative pathogens.

235 st the rising threat of multi-drug-resistant Gram-negative bacteria.

236 a key agent for treatment of drug-resistant Gram-positive infections.

237 Multidrug resistant Gram-negative bacterial infections are an increasing pub

238 tment of a wide range of multidrug resistant Gram-negative bacterial infections, by both intravenous

239 Multidrug-resistant Gram-negative (GN) infections for which there are few av

240 man infections caused by multidrug-resistant Gram-negative bacteria.

241 trum of activity against multidrug-resistant Gram-negative bacteria; however, breakpoints have been e

242 rtunistic and frequently multidrug-resistant Gram-negative bacterial pathogen that primarily infects

243 Treatment of multidrug-resistant Gram-negative bacterial pathogens represents a critical

244 listin) for treatment of multidrug-resistant Gram-negative infections, many clinical laboratories are

245 y/mortality rates with carbapenem-resistant, Gram-negative bacterial infections.

246 ins are covalently attached to PG in several Gram-negative species, including Coxiella burnetii, Agro

247 ross prokaryotes, and in particular, several Gram-negative bacterial pathogens including Neisseria me

248 engineered to attach specifically to several Gram-negative organisms, including the human pathogens E

249 nts, initial staining of liquid media showed Gram-positive rods or cocci, including some cocci in cha

250 CLs did not suspect that slow-growing, small Gram-negative bacteria might be harmful.

251 ng through correlation with direct staining (Gram and calcofluor white) and CSF cryptococcal antigen

252 Not surprisingly, Gram-negative bacteria have evolved diverse posttranslat

253 ng antibacterial activity against the tested Gram-positive and Gram-negative bacteria, with a large z

254 efficacy against Gram-positive strains than Gram-negative ones.

255 he methods of surface charge modulation that Gram-negative organisms may adopt for antibiotic resista

256 The Gram-negative anaerobe, Porphyromonas gingivalis, is a k

257 The Gram-negative bacteria E. coli and P. aeruginosa were pa

258 The Gram-negative Shigella species are close relatives of Es

259 The Gram-positive bacterium Bacillus subtilis uses serine no

260 resistance seems to be universal across the Gram-positive bacteria, while the type of coselected tra

261 isine A showed moderate activity against the Gram-negative bacterium Escherichia coli, but no further

262 tance in the preeminent etiologic agent, the Gram-positive bacterium Staphylococcus aureus Bacterial

263 d aggregate lipopolysaccharide (LPS) and the Gram-negative bacterium Escherichia coli However, the ph

264 : the Gram-negative Escherichia coli and the Gram-positive Bacillus subtilis.

265 teria have one pathway or the other, but the Gram-positive, facultative intracellular pathogen Lister

266 five bacterial diguanylate cyclases from the Gram-negative bacterium Salmonella Enteritidis, identify

267 re, we detected LPS-derived lipid A from the Gram-negative pathogens, Escherichia coli (Ec, m/z 1797)

268 pp, all directly interact with XPRT from the Gram-positive bacterium Bacillus subtilis and inhibit XP

269 ibe the characterization of a MINPP from the Gram-positive bacterium Bifidobacterium longum (BlMINPP)

270 The dextransucrase DSR-OK from the Gram-positive bacterium Oenococcus kitaharae DSM17330 pr

271 In the Gram-negative bacterium Escherichia coli, membrane-bound

272 omplex, which parallel recent studies in the Gram-negative intestinal pathogen Campylobacter jejuni.

273 In the Gram-negative social bacterium, Myxococcus xanthus, a pu

274 In the Gram-positive model bacterium, Bacillus subtilis, the fi

275 otein as a novel PASTA-eSTK substrate in the Gram-positive pathogen Listeria monocytogenes.

276 oped a method to directly detect and map the Gram-negative bacterial virulence factor lipid A derived

277 Chemical-induced spores of the Gram-negative bacterium Myxococcus xanthus are peptidogl

278 The genome of the Gram-negative symbiont Bacteroides thetaiotaomicron, a d

279 rs induce deformation and penetration of the Gram-positive and Gram-negative bacterial cell envelope,

280 ccounting for the physical properties of the Gram-positive cell wall, was developed.

281 investigate and improve understanding of the Gram-positive cellular microenvironment.

282 embraned cells and the derived nature of the Gram-positive envelope following multiple OM losses.

283 vironment of two live bacterial strains: the Gram-negative Escherichia coli and the Gram-positive Bac

284 harges influence their interactions with the Gram-negative bacterial membranes.

285 Infection with the Gram-negative bacterium Helicobacter pylori remains the

286 Infection with the Gram-negative, microaerophilic bacterium Helicobacter py

287 pecies spanning different classes within the Gram-negative phylum Proteobacteria: Agrobacterium tumef

288 diversity and ability to form biofilms, this Gram-negative nonfermenting bacterium can persist in the

289 , PPV and NPVs, and accuracy than culture to Gram stain.

290 nt SmartProbes offer a comparative method to Gram stain for delineating gram-positive or gram-negativ

291 oke fail to increase hepcidin in response to Gram-negative or Gram-positive infection.

292 Here we extend our study to Gram-positive bacteria showing that coupling game-theory

293 otic classes have been approved for treating Gram-negative pathogens in decades.

294 of FMN riboswitch binders against wild-type Gram-negative bacteria.

295 demonstrate label-free readout on unlabeled Gram-negative and Gram-positive species.

296 investigated the binding of CTRP6 to various Gram-negative bacteria as well as PRMs and enzymes of th

297 peptides when the flies were challenged with Gram-positive bacteria Micrococcus luteus In this settin

298 ow-derived macrophages (BMDMs) infected with Gram-negative bacteria such as Citrobacter rodentium, Es

299 nflammasome activation during infection with Gram-negative bacteria.

300 of positive blood cultures in patients with Gram-negative and Gram-positive bacteria, including 8/60